empowered with their medical and behaviour data so they can take greater responsibility for their personal healthcare and share their data with those who need it.
permissioned access to patient data enables more accurate diagnoses and delivers additional, and more rapid, positive outcomes.
INNOVATORS AND RESEARCHERS
build quality cohorts for research at a fraction of the time and cost of current approaches. This enables more conditions to be explored and a new generation of innovators to enter the sector.
SINGLE SOURCE MULTI DATA TYPES (MEDICAL AND BEHAVIOUR )
enables more nuanced research
enables researchers to explore more conditions
GREATER DATA ACCESSIBILITY
Lower barrier to entry enables a new generation of innovators to enter the sector
A VERIFIED CHAIN OF CUSTODY
delivers trustworthy data
QUICKER COHORT BUILD
accelerates time to market
POPULATION SIZED PARTICIPANT POOLS
Reduce the chance of screen failure
The Covid-19 crisis has sharply reminded us that we need more innovators to conduct more research, better, faster and safer than ever. This requires access to the medical and behavioral data of a population sized ‘pool’ of research participants.
Today, building cohorts for research takes months if not years, and can cost up to US$50m per cohort, constraining innovation when we need it the most.
HDX provides a powerful, systemic solution to this problem and is under rapid development.